Lv11
50 积分 2024-11-17 加入
Pulmonary alveolar proteinosis associated with ruxolitinib
44分钟前
求助中
Comparative pharmacovigilance of herpetic infections with dupilumab and JAK inhibitors in atopic dermatitis
22天前
已完结
Efficacy and Safety of Janus Kinase Inhibitors in Systemic Lupus Erythematosus: A Systematic Review and Meta-analysis of Randomized Controlled Trials
23天前
已完结
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial
26天前
已完结
Superior drug retention of selective JAK1 inhibitors compared to pan-JAK inhibitors in rheumatoid arthritis: A meta-analysis of real-world evidence
27天前
已完结
The Efficacy and Safety of Tofacitinib in 48 Children and Adolescents With Alopecia Areata: A Retrospective Study From China
27天前
已完结
Upadacitinib dose increase to 45 mg daily for refractory atopic dermatitis
28天前
已完结
Ibrutinib-induced Sweet syndrome
2个月前
已关闭
Orelabrutinib for systemic lupus erythematosus: A randomised, double-blind, placebo-controlled study
2个月前
已完结
Safety and activity of pirtobrutinib in patients with relapsed or refractory Waldenström macroglobulinaemia: 5-year follow-up of the open-label, multicentre, phase 1/2 BRUIN trial
2个月前
已完结
皖公网安备34019202002308
